Abstract
We report on a case of malignant basal cell carcinoma of the prostate combined with a poorly differentiated conventional adenocarcinoma, infiltrating bilaterally the seminal vesicles and with lymph-node and distant metastases. Basal cell carcinoma represented the prevalent component of the tumour (80%), showed high mitotic activity, extensive perineural infiltration and vascular invasion and was immunoreactive for basal cell related antigens (high molecular weight cytokeratins 34βE12 and p63). Our data confirm previous observations that basal cell carcinoma represents an aggressive tumour with an adverse clinical outcome.
References
Ahn SK, Kim K, Choi IJ, Lee JM (1991) Adenoid cystic carcinoma of the prostate. Yonsei Med J 32:74–77
Bostwick DG (1997) Neoplasms of the prostate. In: Bostwick DG, Eble JN (eds) Urologic surgical pathology. Mosby, St Louis, pp 375–377
Chan SS, Walters MN (1984) Adenoid cystic carcinoma of the prostate. Pathology 16:337–338
Cohen RJ, Goldberg RD, Verhaart MJ, Cohen M (1993) Adenoid cyst-like carcinoma of the prostate gland. Arch Pathol Lab Med 117:799–801
Denholm SW, Webb JN, Howard GC, Chisholm GD (1992) Basaloid carcinoma of the prostate gland: histogenesis and review of the literature. Histopathology 20:151–155
Devaraj LT, Bostwick DG (1993) Atypical basal cell hyperplasia of the prostate. Immunophenotypic profile and proposed classification of basal cell proliferations. Am J Surg Pathol 17:645–659
Eby LS, Johnson DS, Baker HW (1972) Adenoid cystic carcinoma of the head and neck. Cancer 29:1160–1168
Epstein JI (1989) Adenocarcinoma. In: Epstein JI (ed) Prostate biopsy interpretation. Biopsy interpretation series. Raven, New York, pp 120–125
Epstein JI, Armas OA (1992) Atypical basal cell hyperplasia of the prostate. Am J Surg Pathol 16:1205–1214
Frankel K, Craig JR (1974) Adenoid cystic carcinoma of the prostate. Report of a case. Am J Clin Pathol 62:639–645
Gilmour AM, Bell TJ (1986) Adenoid cystic carcinoma of the prostate. Br J Urol 58:105–106
Gleason DF (1966) Classification of prostatic carcinomas. Cancer Chemoter 50:125–128
Gleason DF (1977) Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed) Urologic pathology: the prostate. Lea & Febiger, Philadelphia, pp 171–197
Grignon DJ, Ro JY, Ordonez NG, Ayala AG, Cleary KR (1988) Basal cell hyperplasia, adenoid basal cell tumour, and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study. Hum Pathol 19:1425–1433
Hasan N, Dodd S (1996) Basal cell carcinoma of the prostate. Histopathology 28:571
Kramer SA, Bredael JJ, Krueger RP (1978) Adenoid cystic carcinoma of the prostate: report of a case. J Urol 120:383–384
Kuhajda FP, Mann RB (1984) Adenoid cystic carcinoma of the prostate. A case report with immunoperoxidase staining for prostate-specific acid phosphatase and prostate-specific antigen. Am J Clin Pathol 81:257–260
Minei S, Hachiya T, Ishida H, Okada K (2001) Adenoid cystic carcinoma of the prostate: a case report with immunohistochemical and in situ hybridization staining for prostate-specific antigen. Int J Urol 8:S41–S44
Mostofi FK, Price EB Jr (1973) Malignant tumours of the prostate. In: Atlas of tumours of the male genital system, 2nd series, fascicle. Armed Forces Institute of Pathology, Washington DC, p 244
Oliai BR, Kahane H, Epstein JI (2002) Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34βE12) antibody. Am J Surg Pathol 26:1151–1160
Parson JK, Gage WR, Nelson WG, De Marzo AM (2001) p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis. Urology 58:619–624
Petersen RO (1992) Prostate and seminal vesicles. In: Petersen RO (ed) Urologic pathology, 2nd edn. J.B. Lippincott Co, Philadelphia, p 642
Pruneri G, Pignataro L, Manzotti M, Carboni N, Ronchetti D, Neri A, Cesana BM, Viale G (2002) p63 in laryngeal squamous cell carcinoma: evidence for a role of TA-p63 down-regulation in tumorigenesis and lack of prognostic implications of p63 immunoreactivity. Lab Invest 82:1327–1234
Reed RJ (1984) Consultation case: prostate (prostatectomy)—adenoid basal-cell tumour—multifocal basal-cell hyperplasia. Am J Surg Pathol 8:699–704
Ronnett BM, Epstein JI (1989) A case showing sclerosing adenosis and an unusual form of basal cell hyperplasia of the prostate. Am J Surg Pathol 13:866–872
Schmid HP, Semjonov A, Eltze E, Wortler K, Hertle L (2002) Late recurrence of adenoid cystic carcinoma of the prostate. Scand J Urol Nephrol 36:158–159
Shah RB, Zhou M, Leblanc M, Synder M, Rubin MA (2002) Comparison of the basal cell-specific markers, 34βE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol 26:1161–1168
Tannenbaum M (1975) Adenoid cystic or “salivary gland” carcinomas of prostate. Urology 6:238–239
Urist MJ, Di Como CJ, Lu ML, Charytonowicz E, Verbel D, Crum CP, Ince TA, McKeon FD, Cordon-Cardo C (2002) Loss of p63 expression is associated with tumor progression in bladder cancer. Am J Pathol 161:1199–1206
Yang XJ, McEntee M, Epstein JI (1998) Distinction of basaloid carcinoma of the prostate from benign basal cell lesions by using immunohistochemistry for bcl-2 and Ki-67. Hum Pathol 29:1447–1450
Young RH, Frierson HF Jr, Mills SE, Kaiser JS, Talbot WH, Bhan AK (1988) Adenoid cystic-like tumour of the prostate gland. A report of two cases and review of the literature on “adenoid cystic carcinoma” of the prostate. Am J Clin Pathol 89:49–56
Young RH, Srigley JR, Amin MB, Ulbright TM, Cubilla AL (1998) Variants of prostatic adenocarcinoma, other primary carcinomas of prostate, and secondary carcinomas. In: Atlas of tumours of the prostate gland, seminal vesicles, male urethra, and penis, 3rd series, fascicle 28. Armed Forces Institute of Pathology, Washington DC, pp 230–233
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mastropasqua, M.G., Pruneri, G., Renne, G. et al. Basaloid cell carcinoma of the prostate. Case report and review of the literature. Virchows Arch 443, 787–791 (2003). https://doi.org/10.1007/s00428-003-0911-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-003-0911-2